Clinical Trial Shows Promise of a Functional Cure for Sickle Cell Disease

Gene therapy eliminated pain and improved blood counts in most patients with sickle cell disease in a major trial.

New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease, a genetic blood disorder with few curative options.